Gelteq Limited Ordinary Shares Stock (NASDAQ:GELS)

Financials Chart

Previous Close

$2.34

52W Range

$0.77 - $5.50

50D Avg

$1.62

200D Avg

$1.95

Market Cap

$21.71M

Avg Vol (3M)

$2.81M

Beta

-4.93

Div Yield

-

GELS Company Profile

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

AU

Employees

7

IPO Date

-

Website

GELS Performance

GELS Financial Summary

	Jun 24	Jun 23	Jun 22
Revenue	-	$79.84K	$147.54K
Operating Income	$-2.95M	$-3.10M	$-3.19M
Net Income	$-3.55M	$-3.51M	$-3.37M
EBITDA	$-1.75M	$-1.88M	$-1.98M
Basic EPS	-	$-0.37	$-0.36
Diluted EPS	-	$-0.37	$-0.36

Fiscal year ends in Jun 24 | Currency in AUD